Compound IC50 values in cancer cell lines (pancreatic- Aspc1, BxPC3, PANC1, PANC 04.03, PANC10.05, HPAC, PANC08.13; and the triple negative MDA-MB-231 breast cancer line). These are compared to Bortezomib/Velcade IC50 of about 1-10 µM, depending on the cell line
Funding
MITACS-Accelerate Industrial R&D Internship Program / Programme de Stage en R&D Industrielle MITACS-Accélération